Service Corporation International is a well-known provider of deathcare services and products, with a network of funeral service locations and cemeteries. The company has market cap of $5.76 billion. The Company’s divisions include Funeral, Cemetery and Corporate. It has a 33.94 P/E ratio. It conducts both funeral and cemetery activities in the United States and Canada.
AcelRx Pharmaceuticals Inc (ACRX) formed multiple bottom with $2.41 target or 9.00% below today’s $2.65 share price. AcelRx Pharmaceuticals Inc (ACRX) has $124.68 million valuation. About 165,972 shares traded. AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) has declined 17.17% since September 8, 2016 and is downtrending. It has underperformed by 23.94% the S&P500.
Investors sentiment increased to 2.06 in 2016 Q4. Its up 0.84, from 1.22 in 2016Q3. It improved, as 2 investors sold AcelRx Pharmaceuticals Inc shares while 16 reduced holdings. 15 funds opened positions while 22 raised stakes. 14.54 million shares or 6.63% less from 15.57 million shares in 2016Q3 were reported. Ing Groep Nv holds 13,000 shares or 0% of its portfolio. Vanguard Gru invested in 0% or 1.52M shares. Manchester Cap Mgmt Ltd Liability has invested 0% of its portfolio in AcelRx Pharmaceuticals Inc (NASDAQ:ACRX). Acadian Asset Mgmt Ltd Liability Corporation owns 9,840 shares or 0% of their US portfolio. Blackrock Advisors Ltd Co reported 18,264 shares. D E Shaw owns 150,131 shares for 0% of their portfolio. 45,000 were accumulated by Raymond James Assoc. Perceptive Advsrs Limited Com owns 5.41M shares for 1% of their portfolio. Morgan Stanley reported 0% of its portfolio in AcelRx Pharmaceuticals Inc (NASDAQ:ACRX). Schwab Charles Invest Management accumulated 57,300 shares. Royal Retail Bank Of Canada reported 0% stake. Bankshares Of Montreal Can holds 0% or 43,653 shares. Northern reported 377,636 shares stake. Creative Planning reported 14,600 shares. Goldman Sachs invested in 0% or 21,608 shares.
Analysts await AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) to report earnings on May, 1. They expect $-0.28 EPS, down 27.27% or $0.06 from last year’s $-0.22 per share. After $-0.21 actual EPS reported by AcelRx Pharmaceuticals Inc for the previous quarter, Wall Street now forecasts 33.33% negative EPS growth.
Among 5 analysts covering AcelRx Pharmaceuticals (NASDAQ:ACRX), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. AcelRx Pharmaceuticals has $15 highest and $7 lowest target. $10.83’s average target is 308.68% above currents $2.65 stock price. AcelRx Pharmaceuticals had 11 analyst reports since August 4, 2015 according to SRatingsIntel. Roth Capital maintained the stock with “Buy” rating in Monday, October 5 report. TH Capital maintained the stock with “Buy” rating in Monday, October 5 report. The rating was upgraded by Seaport Global on Friday, May 6 to “Buy”. The rating was maintained by Cowen & Co on Tuesday, August 4 with “Hold”. As per Friday, October 30, the company rating was upgraded by Jefferies. The stock has “Buy” rating by H.C. Wainwright on Tuesday, May 3. H.C. Wainwright initiated the shares of ACRX in report on Wednesday, September 2 with “Buy” rating. TH Capital maintained AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) rating on Thursday, September 15. TH Capital has “Buy” rating and $15 target.
Lombard Odier Asset Management (Switzerland) Sa holds 5.63% of its portfolio in Service Corporation International for 785,000 shares. Gratia Capital Llc owns 441,720 shares or 4.16% of their US portfolio. Moreover, Edgepoint Investment Group Inc. has 4.1% invested in the company for 8.59 million shares. The Texas-based Salient Trust Co Lta has invested 3.62% in the stock. Ivory Investment Management Llc, a California-based fund reported 2.25 million shares.
Since January 1, 0001, it had 0 insider buys, and 9 sales for $16.59 million activity.
Analysts await Service Corporation International (NYSE:SCI) to report earnings on April, 26. They expect $0.30 EPS, up 7.14% or $0.02 from last year’s $0.28 per share. SCI’s profit will be $56.20 million for 25.63 P/E if the $0.30 EPS becomes a reality. After $0.47 actual EPS reported by Service Corporation International for the previous quarter, Wall Street now forecasts -36.17% negative EPS growth.